Analyst Ratings for Aileron Therapeutics Inc (ALRN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/31/2024 | Brookline Capital Markets | N/A | New Coverage | Buy (N/A) |
7.00 (N/A) |
3.21 (2.11) |
-34.27% | Details |
| 12/1/2023 | Ladenburg Thalmann » Updated 4/18/2024 |
Aydin Huseynov | Upgrade | Buy (Neutral) |
19.00 (9.00) |
2.12 (2.11) |
-0.47% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


